FOSAPREPITANT DIMEGLUMINE 150 mg/5mL (Fosaprepitant Dimeglumine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 150 mg/5mL

Fosaprepitant Dimeglumine 150 mg/5mL is a lyophilized powder for intravenous solution, used to manage chemotherapy-induced nausea and vomiting. This medication is designed to provide relief and support during cancer treatment.

Strength

150 mg/5mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9384-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant Dimeglumine is primarily used to prevent nausea and vomiting caused by chemotherapy. It works by blocking substances in the body that can trigger these symptoms, making it a valuable tool in managing the side effects of cancer treatment. Patients often wonder, 'What is Fosaprepitant Dimeglumine used for?' The answer lies in its ability to provide relief from chemotherapy-induced nausea and vomiting, improving the quality of life for those undergoing treatment.

Side Effects

Common effects of Fosaprepitant Dimeglumine may include fatigue, headache, and constipation. Some patients might experience dizziness or diarrhea. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Fosaprepitant Dimeglumine should be handled with care, following the instructions provided by a healthcare professional. It is essential to store the medication properly and use it as directed. Patients with certain medical conditions or allergies should inform their healthcare provider before use.

Avoid Interactions

Fosaprepitant Dimeglumine may interact with other medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.

References

Frequently Asked Questions

Fosaprepitant Dimeglumine is used to prevent nausea and vomiting caused by chemotherapy.

Fosaprepitant Dimeglumine is administered intravenously as a solution prepared from the lyophilized powder.

Common side effects may include fatigue, headache, constipation, dizziness, and diarrhea.

It is important to consult a healthcare provider before using Fosaprepitant Dimeglumine with other medications to avoid potential interactions.

Fosaprepitant Dimeglumine should be stored according to the instructions provided by the manufacturer to maintain its effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.